New-onset psoriasis following treatment with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C

Amir Horev; Sima Halevy

New-onset psoriasis following treatment with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Original language	English
Pages (from-to)	760-761
Number of pages	2
Journal	Israel Medical Association Journal
Volume	11
Issue number	12
State	Published - 1 Dec 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Hepatitis C
Interferon alpha
Psoriasis
Ribavirin

ASJC Scopus subject areas

General Medicine

Cite this

@article{bf17f29576f741d29a08380e183faad8,

title = "New-onset psoriasis following treatment with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C",

keywords = "Hepatitis C, Interferon alpha, Psoriasis, Ribavirin",

author = "Amir Horev and Sima Halevy",

year = "2009",

month = dec,

day = "1",

language = "English",

volume = "11",

pages = "760--761",

journal = "Israel Medical Association Journal",

issn = "1565-1088",

publisher = "Israel Medical Association",

number = "12",

}

TY - JOUR

T1 - New-onset psoriasis following treatment with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C

AU - Horev, Amir

AU - Halevy, Sima

PY - 2009/12/1

Y1 - 2009/12/1

KW - Hepatitis C

KW - Interferon alpha

KW - Psoriasis

KW - Ribavirin

UR - https://www.scopus.com/pages/publications/75449119906

M3 - Article

C2 - 20166347

AN - SCOPUS:75449119906

SN - 1565-1088

VL - 11

SP - 760

EP - 761

JO - Israel Medical Association Journal

JF - Israel Medical Association Journal

IS - 12

ER -

New-onset psoriasis following treatment with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C

UN SDGs

Keywords

ASJC Scopus subject areas

Other files and links

Cite this